CytoMed Therapeutics

About:

CytoMed Therapeutics is a cancer immunotherapy startup.

Top Investors: SV Health Investors, mDR Group

Description:

CytoMed Therapeutics is a spin-off from Singapore's Agency for Science, Technology, and Research (A*Star) that focuses on turning its patented technology into "off-the-shelf" immunotherapeutics based on gamma delta () T cells and natural killer (NK) cells treating a variety of tumors. CytoMed also generates induced pluripotent stem cells (iPSCs) and develops them into cellular medicines for its customers utilizing patented technology.

Total Funding Amount:

1.5M SGD

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Singapore, Central Region, Singapore

Founded Date:

2018-01-01

Contact Email:

enquiry(AT)cytomed.sg

Founders:

Number of Employees:

11-50

Last Funding Date:

2020-01-01

IPO Status:

Public

Industries: